NCT04756765 2025-08-17
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Stanford University
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT06762808 2025-08-15
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02127151 2021-08-06
PANDA
University College, London
Phase 2 Withdrawn
NCT02836028 2018-09-18
A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
Pfizer
Phase 2 Withdrawn